Bicycle Therapeutics (BCYC)

AI Score

Unlock

8.60

-0.07 (-0.81%)

At close: Apr 24, 2025, 3:59 PM

8.32

-3.26%

Pre-market: Apr 25, 2025, 04:36 AM EDT

Bicycle Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q1 2018	Q4 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Mar 31, 2018	Dec 31, 2017
Cash & Equivalents	879.52M	890.86M	961.36M	457M	526.42M	572.09M	340.43M	293.81M	339.15M	361.47M	372.77M	407.37M	438.68M	259.52M	198.74M	195.9M	135.99M	149.84M	96.91M	109.64M	92.12M	95.95M	108.54M	59.37M	63.38M	47.92M	-67.66M	67.66M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	135.33M	n/a
Long-Term Investments	n/a	547K	547K	547K	547K	548K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	11.07M	9.39M	6.03M	5.82M	5.25M	4.9M	12.15M	10.57M	8.46M	6.16M	5.1M	4.2M	3.45M	2.78M	2.38M	2.18M	1.82M	2.4M	2.27M	1.87M	1.7M	1.48M	1.41M	3.49M	3.04M	1.16M	-67.66M	1.13M
Receivables	35.65M	57.98M	46.68M	39.06M	24.04M	17.28M	57.97M	76.51M	21.21M	11.37M	26.27M	13.33M	11.91M	7.7M	14.26M	13.53M	14.63M	8.8M	11.3M	9.51M	7.14M	10.76M	9.89M	8.33M	11.31M	5.32M	n/a	n/a
Inventory	n/a	n/a	1.00	1.00	n/a	n/a	n/a	1.00	1.00	n/a	1.00	n/a	n/a	n/a	n/a	1.00	n/a	1.00	n/a	n/a	1.00	n/a	1.00	n/a	n/a	n/a	n/a	n/a
Other Current Assets	13.43M	17.35M	20.22M	19.9M	11.41M	13.67M	10.02M	10.93M	9.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.62M	n/a	3M
Total Current Assets	928.61M	966.19M	1.03B	515.96M	561.87M	603.04M	408.43M	381.25M	369.38M	381.29M	408.49M	429.77M	458.56M	272.87M	217.79M	215.39M	155.72M	164.16M	112.53M	123.39M	104.15M	110.25M	120.45M	69.93M	76.77M	59.56M	67.66M	71.51M
Property-Plant & Equipment	17.19M	20.61M	22.52M	24.81M	27.68M	30.2M	33.59M	36.98M	32.77M	29.7M	31.89M	25.6M	17.79M	5.68M	5.88M	6.27M	3.61M	3.5M	3.8M	4.02M	4.35M	4.33M	4.39M	4.39M	1.82M	1.61M	n/a	1.36M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	28.26M	30.55M	29.1M	31.18M	33.48M	35.65M	45.74M	47.55M	41.23M	35.86M	36.99M	29.8M	21.24M	8.46M	8.26M	8.45M	5.43M	5.9M	6.07M	5.89M	6.05M	5.81M	5.79M	7.88M	4.86M	2.78M	-67.66M	2.49M
Total Assets	956.87M	996.75M	1.06B	547.14M	595.34M	638.68M	454.17M	428.8M	410.61M	417.15M	445.48M	459.56M	479.79M	281.33M	226.05M	223.84M	161.15M	170.06M	118.6M	129.28M	110.19M	116.06M	126.25M	77.8M	81.63M	62.34M	n/a	74M
Account Payables	15.79M	5.71M	7.45M	7.06M	13.05M	8.49M	5.25M	2.81M	6.47M	7.06M	4.86M	4M	2.72M	1.76M	3.47M	996K	1.36M	2.06M	3.34M	4.43M	1.95M	1.99M	2.57M	2.24M	1.89M	1.11M	n/a	2.06M
Deferred Revenue	10.19M	11.38M	11.62M	16.42M	24.98M	27.19M	29.75M	24.97M	20.42M	16.4M	19.53M	19.15M	19.27M	17.46M	8.74M	10.09M	10.13M	7.19M	5.42M	6.05M	728K	808K	1.01M	24K	10K	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	22.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.57M	20.78M	13.8M	5.72M	13.24M	10.06M	23.55M	13.72M	13.4M	8.95M	5.51M	6.6M	7M	4.25M	2.88M	1.86M	6.39M	2.65M	1.96M	3.99M	2.58M	1.57M	3.83M	619K	5.41M	1.18M	n/a	5.7M
Total Current Liabilities	67.23M	56.41M	69.61M	49.51M	69.54M	69.74M	72.27M	52.99M	53.34M	41.55M	41.34M	35.41M	36.24M	30.18M	23.27M	20.81M	23.13M	17.05M	16.98M	16.2M	8.82M	8.84M	9.44M	8.42M	8.93M	7.71M	n/a	9.45M
Long-Term Debt	n/a	n/a	8.51M	30.8M	30.7M	30.6M	30.51M	30.42M	30.32M	30.23M	30.14M	30.01M	29.87M	29.75M	29.63M	29.5M	14.51M	14.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.12M	5.96M	4.7M	4.61M	4.58M	4.32M	4.33M	4.08M	3.83M	3.16M	3.26M	3.36M	3.28M	3.04M	2.96M	2.81M	2.61M	2.31M	2.08M	2.01M	2M	1.43M	1.26M	1.05M	127.9M	n/a	n/a	n/a
Total Long-Term Liabilities	96.58M	109.31M	113.93M	141.59M	154.88M	152.93M	161.81M	132.64M	86.48M	86.12M	92.75M	93.89M	97.3M	80.33M	60.73M	60.95M	42.56M	43.46M	30.6M	31.27M	8.18M	11.9M	12.25M	12.47M	142.52M	n/a	n/a	n/a
Total Liabilities	163.81M	165.71M	183.54M	191.09M	224.41M	222.66M	234.07M	185.64M	139.83M	127.67M	134.09M	129.31M	133.54M	110.51M	84M	81.75M	65.69M	60.51M	47.58M	47.47M	17M	20.73M	21.69M	20.89M	151.45M	7.71M	n/a	9.45M
Total Debt	9.49M	11.09M	42.74M	43.82M	44.96M	45.69M	47.07M	49.47M	44.33M	44.04M	45.55M	47.1M	44.34M	33.07M	33.2M	33.23M	15.78M	15.76M	1.5M	1.69M	1.89M	2.02M	2.22M	2.42M	n/a	n/a	n/a	n/a
Common Stock	890K	890K	889K	553K	550K	550K	396K	389K	387K	385K	385K	385K	384K	329K	309K	300K	266K	264K	228K	227K	227K	226K	226K	173K	10K	5K	n/a	4K
Retained Earnings	-680.79M	-628.94M	-578.13M	-538.32M	-511.76M	-462.66M	-412.76M	-370.16M	-331.1M	-301.12M	-272.77M	-245.94M	-218.38M	-200.34M	-185.66M	-167.75M	-151.56M	-134.13M	-123.99M	-111.87M	-100.55M	-96.14M	-86.66M	-76.44M	-69.94M	-62.54M	n/a	-48.1M
Comprehensive Income	119K	-3.19M	-1.09M	-778K	-1.3M	2.88M	-877K	71K	387K	528K	-374K	-2.47M	-3.39M	-3.19M	-3.51M	-3.25M	-3.19M	-2.98M	-3.72M	-3.72M	-1.53M	-2.61M	-2.18M	-671K	-1.75M	-1.34M	-47.18M	69K
Shareholders Equity	793.06M	831.03M	873.81M	356.05M	370.93M	416.02M	220.1M	243.16M	270.78M	289.47M	311.39M	330.26M	346.25M	170.82M	142.05M	142.09M	95.46M	109.55M	71.03M	81.81M	93.2M	95.33M	104.56M	56.91M	-69.83M	28.63M	49.26M	49.26M
Total Investments	n/a	547K	547K	547K	547K	548K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	135.33M	n/a